-
Published on Aug 15, 2016
Akers
Biociences Inc co-founder and chief scientific director Ray Akers told
Proactive that investors should focus now on its products from its
digital health and wellness platform in 2017 and beyond.
The response to these has been "greater than anything I've seen in my career," he told Sarah Lowther.
"We are seeing some real possibilities for explosive growth here in areas we didn't even contemplate when we developed these tests."
It came after the group posted a 47% increase in product revenue in the first half to almost US$1.7mln, while the rise in total revenue was 15%.
"We are so excited about the improvements all across our company - in revenues, in gross margins, in shrinking losses as we approach profitability," Akers told Proactive.
www.akersbio.com/
http://www.4-traders.com/AKERS-BIOSCIENCES-INC-15590054/
No comments:
Post a Comment